{
  "id": 5610,
  "text": "International Journal of Clinical Oncology, 23, 522-531.https://doi.org/10.1007/s10147-017-1225-8 [6] Stolnicu, S., Barsan, I., Hoang, L., et al.(2018) International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: International Journal of Clinical Oncology, 23, 522-531.https://doi.org/10.1007/s10147-017-1225-8 [6] Stolnicu, S., Barsan, I., Hoang, L., et al.(2018) International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据国际子宫颈腺癌新分类标准 IECC（International Endocervical Adenocarcinoma Criteria and Classification），宫颈内膜腺癌的病理分类重点转向基于肿瘤的致病途径而非传统的形态学分类。IECC 将宫颈腺癌分为两大类：**HPV 相关型腺癌**和**非 HPV 相关型腺癌**。\n\n- **HPV 相关性腺癌**：主要由高风险型 HPV 感染引起（如 HPV 16、18），在病理组织学上常表现为胞质含量少、呈暗染的胞核以及局部见肿瘤细胞的腺体结构增加。该类型包括以往的子类型如：典型的内乳头状腺癌、黏液型腺癌。\n  \n- **非 HPV 相关型腺癌**：不与 HPV 感染相关，通常表现为较大的胞质性、胞浆变性以及多样化的腺体分化形式，比如胃型腺癌和透明细胞癌。这种类型往往在预后和治疗方案上与 HPV 相关型有所不同。\n\n这种分类方法的临床意义在于通过明确的致病机制指导更精准的诊断、治疗以及预后评估。",
  "query": "什么是用于宫颈内膜腺癌的新病理分类标准？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 什么是用于宫颈内膜腺癌的新病理分类标准？\n\n<reference text>: International Journal of Clinical Oncology, 23, 522-531.https://doi.org/10.1007/s10147-017-1225-8 [6] Stolnicu, S., Barsan, I., Hoang, L., et al.(2018) International Endocervical Adenocarcinoma Criteria and Classification (IECC): A New Pathogenetic Classification for Invasive Adenocarcinomas of the Endocervix.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据国际子宫颈腺癌新分类标准 IECC（International Endocervical Adenocarcinoma Criteria and Classification），宫颈内膜腺癌的病理分类重点转向基于肿瘤的致病途径而非传统的形态学分类。IECC 将宫颈腺癌分为两大类：**HPV 相关型腺癌**和**非 HPV 相关型腺癌**。\n\n- **HPV 相关性腺癌**：主要由高风险型 HPV 感染引起（如 HPV 16、18），在病理组织学上常表现为胞质含量少、呈暗染的胞核以及局部见肿瘤细胞的腺体结构增加。该类型包括以往的子类型如：典型的内乳头状腺癌、黏液型腺癌。\n  \n- **非 HPV 相关型腺癌**：不与 HPV 感染相关，通常表现为较大的胞质性、胞浆变性以及多样化的腺体分化形式，比如胃型腺癌和透明细胞癌。这种类型往往在预后和治疗方案上与 HPV 相关型有所不同。\n\n这种分类方法的临床意义在于通过明确的致病机制指导更精准的诊断、治疗以及预后评估。"
}